Literature DB >> 10590151

Alpha-glucosidase inhibitors reduce dengue virus production by affecting the initial steps of virion morphogenesis in the endoplasmic reticulum.

M P Courageot1, M P Frenkiel, C D Dos Santos, V Deubel, P Desprès.   

Abstract

We report that endoplasmic reticulum alpha-glucosidase inhibitors have antiviral effects on dengue (DEN) virus. We found that glucosidase inhibition strongly affects productive folding pathways of the envelope glycoproteins prM (the intracellular glycosylated precursor of M [membrane protein]) and E (envelope protein): the proper folding of prM bearing unprocessed N-linked oligosaccharide is inefficient, and this causes delayed formation of prME heterodimer. The complexes formed between incompletely folded prM and E appear to be unstable, leading to a nonproductive pathway. Inhibition of alpha-glucosidase-mediated N-linked oligosaccharide trimming may thus prevent the assembly of DEN virus by affecting the early stages of envelope glycoprotein processing.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10590151      PMCID: PMC111573          DOI: 10.1128/jvi.74.1.564-572.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  33 in total

Review 1.  Lectins as chaperones in glycoprotein folding.

Authors:  E S Trombetta; A Helenius
Journal:  Curr Opin Struct Biol       Date:  1998-10       Impact factor: 6.809

Review 2.  Flavivirus genome organization, expression, and replication.

Authors:  T J Chambers; C S Hahn; R Galler; C M Rice
Journal:  Annu Rev Microbiol       Date:  1990       Impact factor: 15.500

3.  Flavivirus premembrane protein cleavage and spike heterodimer secretion require the function of the viral proteinase NS3.

Authors:  M Lobigs
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

4.  Regulation of the late events in flavivirus protein processing and maturation.

Authors:  V F Yamshchikov; R W Compans
Journal:  Virology       Date:  1993-01       Impact factor: 3.616

5.  Differences between cell membrane fusion activities of two dengue type-1 isolates reflect modifications of viral structure.

Authors:  P Desprès; M P Frenkiel; V Deubel
Journal:  Virology       Date:  1993-09       Impact factor: 3.616

6.  NS2B-3 proteinase-mediated processing in the yellow fever virus structural region: in vitro and in vivo studies.

Authors:  S M Amberg; A Nestorowicz; D W McCourt; C M Rice
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

7.  Recombinant vaccinia viruses co-expressing dengue-1 glycoproteins prM and E induce neutralizing antibodies in mice.

Authors:  B A Fonseca; S Pincus; R E Shope; E Paoletti; P W Mason
Journal:  Vaccine       Date:  1994       Impact factor: 3.641

8.  Proper maturation of the Japanese encephalitis virus envelope glycoprotein requires cosynthesis with the premembrane protein.

Authors:  E Konishi; P W Mason
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

9.  Secretion of human hepatitis B virus is inhibited by the imino sugar N-butyldeoxynojirimycin.

Authors:  T M Block; X Lu; F M Platt; G R Foster; W H Gerlich; B S Blumberg; R A Dwek
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-15       Impact factor: 11.205

Review 10.  Alpha-glucosidase inhibitors as potential broad based anti-viral agents.

Authors:  A Mehta; N Zitzmann; P M Rudd; T M Block; R A Dwek
Journal:  FEBS Lett       Date:  1998-06-23       Impact factor: 4.124

View more
  69 in total

1.  Folding and dimerization of tick-borne encephalitis virus envelope proteins prM and E in the endoplasmic reticulum.

Authors:  Ivo C Lorenz; Steven L Allison; Franz X Heinz; Ari Helenius
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

2.  Intracellular assembly and secretion of recombinant subviral particles from tick-borne encephalitis virus.

Authors:  Ivo C Lorenz; Jürgen Kartenbeck; Anna Mezzacasa; Steven L Allison; Franz X Heinz; Ari Helenius
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

3.  Two distinct size classes of immature and mature subviral particles from tick-borne encephalitis virus.

Authors:  Steven L Allison; Yizhi J Tao; Gabriel O'Riordain; Christian W Mandl; Stephen C Harrison; Franz X Heinz
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

4.  Class II ADP-ribosylation factors are required for efficient secretion of dengue viruses.

Authors:  Mateusz Kudelko; Jean-Baptiste Brault; Kevin Kwok; Ming Yuan Li; Nathalie Pardigon; J S Malik Peiris; Roberto Bruzzone; Philippe Desprès; Béatrice Nal; Pei Gang Wang
Journal:  J Biol Chem       Date:  2011-11-21       Impact factor: 5.157

5.  A short N-terminal peptide motif on flavivirus nonstructural protein NS1 modulates cellular targeting and immune recognition.

Authors:  Soonjeon Youn; Hyelim Cho; Daved H Fremont; Michael S Diamond
Journal:  J Virol       Date:  2010-06-30       Impact factor: 5.103

6.  Comparative proteomic analysis of HIV-1 particles reveals a role for Ezrin and EHD4 in the Nef-dependent increase of virus infectivity.

Authors:  Christelle Brégnard; Alessia Zamborlini; Marjorie Leduc; Philippe Chafey; Luc Camoin; Ali Saïb; Serge Benichou; Olivier Danos; Stéphane Basmaciogullari
Journal:  J Virol       Date:  2013-01-16       Impact factor: 5.103

7.  Assembly and maturation of the flavivirus Kunjin virus appear to occur in the rough endoplasmic reticulum and along the secretory pathway, respectively.

Authors:  J M Mackenzie; E G Westaway
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

8.  Dengue Virus Evolution under a Host-Targeted Antiviral.

Authors:  Emily Plummer; Michael D Buck; Marisa Sanchez; Jason A Greenbaum; Julia Turner; Rajvir Grewal; Brennan Klose; Aruna Sampath; Kelly L Warfield; Bjoern Peters; Urban Ramstedt; Sujan Shresta
Journal:  J Virol       Date:  2015-03-11       Impact factor: 5.103

9.  Hijacking of host calreticulin is required for the white spot syndrome virus replication cycle.

Authors:  Apiruck Watthanasurorot; Enen Guo; Sirinit Tharntada; Chu-Fang Lo; Kenneth Söderhäll; Irene Söderhäll
Journal:  J Virol       Date:  2014-05-07       Impact factor: 5.103

10.  Universal Dengue Vaccine Elicits Neutralizing Antibodies against Strains from All Four Dengue Virus Serotypes.

Authors:  Naoko Uno; Ted M Ross
Journal:  J Virol       Date:  2021-01-28       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.